| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9155338 | American Heart Journal | 2005 | 6 Pages |
Abstract
Levosimendan, given intravenously after a PCI procedure in patients with AMI and LV dysfunction, significantly improves hemodynamics and CFR, compared with placebo.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Leonardo MD, Paola MD, Annalisa MD, Chiara MD, Giulia MD, Angelo MD, Gennaro MD, Igino MD, Francesco MD,